SCM
TYRA icon

Sterling Capital Management’s Tyra Biosciences TYRA Stock Holding History

Sterling Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12K Sell
129
-729
-85% -$24.1K ﹤0.01% 2722
2026
Q1 		$32.9K Sell
858
-630
-42% -$20.4K ﹤0.01% 1809
2025
Q4 		$39.1K Sell
1,488
-174
-10% -$3.2K ﹤0.01% 1896
2025
Q3 		$23.3K Buy
1,662
+1,012
+156% +$11.5K ﹤0.01% 2077
2025
Q2 		$6.22K Buy
650
+629
+2,995% +$5.98K ﹤0.01% 2398
2025
Q1 		$195 Hold
21
– – ﹤0.01% 3087
2024
Q4 		$292 Hold
21
– – ﹤0.01% 3083
2024
Q3 		$494 Buy
+21
New +$441 ﹤0.01% 2876

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Sterling Capital Management's TYRA Position: Q2 2026 in Review

Sterling Capital Management reduced its Tyra Biosciences (TYRA) stake by 85% in Q2 2026, selling an estimated $24.1K and leaving 129 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Sterling Capital Management first reported a position in TYRA in Q3 2024 and has held it in 8 quarters since. The position peaked at $39.1K in Q4 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Sterling Capital Management held 129 shares of Tyra Biosciences worth $4.12K as of Q2 2026.
  • Sterling Capital Management sold 729 Tyra Biosciences shares in Q2 2026, an estimated $24.1K.
  • Tyra Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2722 holding.
  • Sterling Capital Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Tyra Biosciences position peaked at $39.1K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.